nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

01.12.2016 | Original Article

Single Versus Dual Platform Analysis for Hematopoietic Stem Cell Enumeration Using ISHAGE Protocol

verfasst von: Rahul Naithani, Nitin Dayal, Gaurav Dixit

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Hematopoietic stem cell transplantation is curative therapy in benign and malignant diseases. Adequate stem cell dose is one of the most important marker of engraftment. Several methods have been developed to enumerate CD34+ cells. We present our data on 147 samples analysis. There was a clear linear correlation between two methods. Both methods were effective. Both single vs dual platform analysis yield similar results. Single platform analysis is easier to perform. In terms of cost reduction dual platform analysis is better.

Allan DS, Keeney M, Howson-Jan K et al (2002) Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 29(12):967–972CrossRefPubMed

Ngoma A, Saito S, Ohto H, Ikeda K, Yasuda H, Kawabata K, Kanno T, Kikuta A, Mochizuki K, Nollet KE (2011) CD34+ cell enumeration by flow cytometry: a comparison of systems and methodologies. Arch Pathol Lab Med 135(7):909–914PubMed

Fritsch G, Stimpfl M, Kurz M et al (1996) The composition of CD34 subpopulations differs between bone marrow, blood and cord blood. Bone Marrow Transplant 17(2):169–178PubMed

Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR (1998) Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines; International Society of Hematotherapy and Graft Engineering. Cytometry 34(2):61–70CrossRefPubMed

Chapple P, Prince HM, Wall D, Filshie R, Haylock D, Quinn M, Bretell M, Venter D (2000) Comparison of three methods of CD34+ cell enumeration in peripheral blood: dual-platform ISHAGE protocol versus single-platform, versus microvolume fluorimetry. Cytotherapy 2(5):371–376CrossRefPubMed

Barbosa IL, Sousa ME, Godinho MI, Sousa F, Carvalhais A (1999) Single-versus dual-platform assays for human CD34 cell enumeration. Cytometry 38:274–279CrossRefPubMed

Gratama JW, Orfao A, Barnett D et al (1998) Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells; European Working Group on Clinical Cell Analysis. Cytometry 34(3):128–142CrossRefPubMed

Chin-Yee I, Anderson L, Keeney M, Sutherland DR (1997) Quality assurance of stem cell enumeration by flow cytometry; Canadian QASE Study Group. Cytometry 30(6):296–303CrossRefPubMed

Mercolino TJ, Connelly MC, Meyer EJ et al (1995) Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determinations. Cytometry 22(1):48–59CrossRefPubMed

10.

Strauss K, Hannet I, Engels S et al (1996) Performance evaluation of the FACSCount System: a dedicated system for clinical cellular analysis. Cytometry 26(1):52–59CrossRefPubMed

11.

Chang A, Ma DDF (1997) The influence of flow cytometric gat- ing strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. J Hematother 5:605–616CrossRef

12.

Robinson G, Morgan L, Evans M et al (1992) Effect of type of haematology analyser on CD4 count. Lancet 340(8817):485CrossRefPubMed

Titel: Single Versus Dual Platform Analysis for Hematopoietic Stem Cell Enumeration Using ISHAGE Protocol
verfasst von: Rahul Naithani
Nitin Dayal
Gaurav Dixit
Publikationsdatum: 01.12.2016
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 3/2017
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-016-0749-9

Neu im Fachgebiet Onkologie

24.04.2024 | DGIM 2024 | Nachrichten

Springer Medizin

Single Versus Dual Platform Analysis for Hematopoietic Stem Cell Enumeration Using ISHAGE Protocol

Abstract

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Oleuropein Ameliorates Cisplatin-induced Hematological Damages Via Restraining Oxidative Stress and DNA Injury

Incidence and Residual Risk of HIV, HBV and HCV Infections Among Blood Donors in Tehran

Skin GVHD Mimicking Betadine Rash in a Post Allogeneic Transplant Patient

Mutation Analysis in Chronic Myeloid Leukemia Patient in Chronic Phase on Imatinib Having Delayed Achievement of Milestones or Loss of Response

The Lymphocyte–Monocyte Ratio and the Platelet–Lymphocyte Ratio at Diagnosis as Independent Prognostic Factors in Primary Gastrointestinal Diffuse Large B Cell Lymphoma

Effect of Intravenous Iron Supplementation on Hepcidin Levels in Iron Deficient Pregnant Females in Second and Third Trimester

Neu im Fachgebiet Onkologie

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Update Onkologie